Opinion
Video
Author(s):
Ted Lain, MD, MBA, FAAD discusses balancing vitiligo treatments with coverage challenges.
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Management of Atopic Dermatitis With Hand and Foot Involvement
Switching Gears in Atopic Dermatitis: How Upadacitinib Helps Patients Reach Optimal Targets After Dupilumab Inadequacy
Corvus Pharmaceuticals’ Soquelitinib Shows Rapid, Dose-Dependent Efficacy in Phase 1 AD Trial
Abrocitinib Shows Age-Linked Safety Differences
#DermTok: Navigating TikTok’s Acne Advice Misinformation